eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | angiosarcoma |
| Comorbidity | C0039101|synovial sarcoma |
| Sentences | 2 |
| PubMedID- 25928192 | Among the sarcoma group, myeloid sarcomas had the best prognosis (patient alive at study endpoint) followed by synovial sarcomas (mean survival of 64.00 ± 0.0 months), angiosarcomas (25.3 ± 17.6 months), spindle cell sarcomas and myxofibrosarcomas (both 7.0 ± 0.0 months) and pleomorphic sarcomas (0.0 ± 0.0 months). |
| PubMedID- 21837668 | First, increasing evidence suggests that patients with certain sts histologies may benefit from specific treatments, such as paclitaxel or sorafenib in those with angiosarcomas and ifosfamide in patients with synovial sarcomas. |
Page: 1